MANILA, Philippines — Malacañang has ordered the Food and Drug Administration (FDA) to take charge of identifying actions against illegal trading or distribution of Ivermectin, the anti-parasitic drug that some sectors believe can treat COVID-19 infections.
Ivermectin is approved as an oral and intravenous preparation to prevent heartworm disease and to treat internal and external parasites in some animals, according to the FDA website.
For human use, Ivermectin is registered as a prescription drug in topical formulation for the treatment of external parasites like head lice and some skin conditions, the regulator added.
However, it is not yet included in the list of drugs for COVID-19 treatment.
“To ensure the safety and welfare of the public and at the same time avoid any unnecessary conflicts, the Food and Drug Administration has been directed to take the lead in determining the course of action against the illegal trading/dispensing of Ivermectin,” presidential spokesman Harry Roque said in a statement.
“The Philippine National Police cannot arbitrarily determine, on their own, which drug/s should not be on the market. All operations to apprehend or seize goods must be done in coordination with the FDA,” he added.
Roque said the move aims to clamp down on the sale or trade of Ivermectin for veterinary use that has been repackaged as human grade, including those that have not been determined by competent authorities as safe for human use.
“Having said this, we advise the public to seek the advice of medical practitioners before taking medicines and/or supplements,” the Palace spokesman said.
In a statement issued late last month, the FDA clarified that there is no ban on the purchase and use of Ivermectin as long as such product is registered with the food and drug regulator.
Roque said President Duterte is closely monitoring the developments concerning Ivermectin here and abroad.